K+N invests in overland pharma fleet

Kuehne + Nagel (K+N) is strengthening its European pharma fleet as the market for temperature-controlled shipments continues to grow.

The forwarder has deployed 35 new pharma trailers and will add a further 45 before the end of this year – plus another 200 in the coming years – in order to ensure its PharmaChain overland service provides sufficient capacity as part of a multimodal door-to-door solution for the region’s pharma industry.

Uwe Hött, senior vice president overland, said: “Logistics solutions for the pharma and healthcare industry are among the most important growth drivers for Kuehne + Nagel’s overland and regional business.

“This investment is part of our commitment to provide comprehensive, GxP compliant transport solutions for the industry, which can be tailored to specific needs.”

Read more pharma logistics news

Click here for a free digital subscription

Share this story

Related Topics

Latest freight forwarder news

Hope Consortium adds more forwarders to Covid-19 vaccine distribution efforts

By Damian Brett

More freight forwarders have joined the Hope Consortium, a UAE-based public-private partnership, to support the distribution of Covid-19 vaccines across…

Read More

Share this story

DB Schenker expands airfreight charter network to three continents

By Damian Brett

DB Schenker has extended its own-controlled charter network with a route covering America, Europe and Asia. The service was launched…

Read More

Share this story

DB Schenker restarts UK-Europe road services

By Damian Brett

DB Schenker will today restart road services between Europe and the UK after temporarily suspending them as companies adjusted to…

Read More

Share this story